Gabrielle Meyers

5PUBLICATIONS
61CO-AUTHORS
Autonomic nervous systemGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 30, 2026
Early neurologic response predicts outcomes after anakinra for immune effector cell-associated neurotoxicity syndrome.

|May 21, 2025
Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.

Curtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena

|Feb 27, 2025
Correction: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.

Gabrielle Meyers, Mehdi Hamadani, Michael Martens

|Sep 25, 2023
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.

Gabrielle Meyers, Mehdi Hamadani, Michael Martens

|Nov 24, 2021
Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHD.

Gabrielle Meyers, Mehdi Hamadani, Michael Martens

Pageof 1

Frequent Collaborators

4 joint publications

Richard T Maziarz

3 joint publications

Mehdi Hamadani

3 joint publications

Michael Martens

3 joint publications

Haris Ali